Patients with benzodiazepine dependence in substance dependence treatment: baseline characteristics and comorbidities

References

• Anton RF, Moak DH, Latham PK. 1996. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 53(3):225–231.
   PubMed Web of Science ®Google Scholar
• Ashton H. 2005. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 18(3):249–255.
   PubMed Web of Science ®Google Scholar
• Bakker A, Streel E. 2017. Benzidiazepine maintenance in opiate substitution treatment: good or bad? Aretrospective primary care case-note review. J Psychopharmacol. 31(1):62–66.
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. 2013. Benzodiazepines: risks and benefits. A reconsideration. J Psychopharmacol. 27(11):967–971.
   PubMed Web of Science ®Google Scholar
• Beaufort I, De Weert-Van Oene GH, Buwalda VJA, De Leeuw JRJ, Goudriaan AE. 2017. The depression, anxiety and stress scales (DASS-21) as a screener for depression in substance use disorder inpatients: a pilot study. Eur Addict Res. 23(5):260–268. 2017,
   PubMed Web of Science ®Google Scholar
• Cosci F, Mansueto G, Faccini M, Casari R, Lugoboni F. 2016. Socio-demographic and clinical characteristics of benzodiazepine long-term users: results from a tertiary care center. Compr Psychiatry. 69:2011–2015.
   Web of Science ®Google Scholar
• De Wildt WA, Lehert P, Schippers GM, Nakovics H, Mann K, Van Den Brink W. 2005. Investigating the structure of craving using structural equation modeling in analysis of the obsessive-compulsive drinking scale: a multinational study. Alcohol Clin Exp Res. 29(4):509–516.
   PubMed Web of Science ®Google Scholar
• Darke S, Mills K, Teesson M, Ross J, Williamson A, Havard A. 2009. Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psych Res. 166(1):7–14.
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2004. Guideline detoxification. [accessed 2017 Jan 30]. www.emcdda.europa.eu/attachements.cfm/att_231334_EN_NL01_detox.pdf
   Google Scholar
• Lader M. 2011. Benzodiazepines revisited-will we ever learn?. Addiction. 106(12):2086–2109.
   PubMed Web of Science ®Google Scholar
• Langenbucher JW, Labouvie E, Martin CS, Sanjuan PM, Bavly L, Kirisci L, Chung T. 2004. An Application of Item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV. J Abnorm Psychology. 113(1):72–80.
   PubMed Web of Science ®Google Scholar
• Lovibond PF, Lovibond SH. 1995. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 33(3):335–343.
   PubMed Web of Science ®Google Scholar
• Lugoboni F, Mirijello A, Faccini M, Casari R, Cossari A, Musi G, Bissoli G, Quaglio G, Addolorato G. 2014. Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug Alcohol Depend. 142:105–109.
   PubMed Web of Science ®Google Scholar
• Manthey L, Van Veen T, Giltay EJ, Stoop JE, Knuistingh Neven A, Penninx BWJH, Zitman FG. 2011. Correlates of (inappropriate) benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA). Br J Clin Pharmacol. 71(2):263–272.
   PubMed Web of Science ®Google Scholar
• Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J. 1998. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction. 93(12):1857–1867.
   PubMed Web of Science ®Google Scholar
• Mol AJJ, Gorgels WJMJ, Oude Voshaar RC, Breteler MHM, van Balkom AJLM, van de Lisdonk EH, Kan CC, Zitman FG. 2005. Associations of benzodiazepine craving with other clinical variables in a population of general practice patients. Compr Psychiatry. 46(5):353–360.
   PubMed Web of Science ®Google Scholar
• Moran P, Leese M, Lee T, Walters P, Thornicroft G, Mann A. 2003. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 183(03):228–232.
   PubMedGoogle Scholar
• Morel A, Grall-Bronnec M, Bulteau S, Chauvin-Grelier P, Gailledrat L, Pinot ML, Jolliet P, Victorri-Vigneau C. 2016. Benzodiazepine dependence in subjects with alcohol use disorders: what prevalence?. Expert Opin Drug Saf. 15(10):1313–1319.
   PubMed Web of Science ®Google Scholar
• Moses TEH, Lundahl LH, Greenwald MK. 2018. Factors associated with sedative use and misuse among heroin users. Drug and Alcohol Depend. 185:10–16.
   PubMed Web of Science ®Google Scholar
• Neutel CI. 2005. The epidemiology of long-term benzodiazepine use. Int Rev Psychiatry. 17(3):189–197.
   PubMed Web of Science ®Google Scholar
• Paling E, Dijkstra B, De Jong C, Schellekens A. 2015. Prevalence and treatment of benzodiazepine dependence [article in Dutch: prevalentie en behandeling van benzodiazepineverslaving]. Gedragstherapie. 48(2):185–198.
   Google Scholar
• Psychology Foundation of Australia 2011. Depression Anxiety Stress Scale - DASS. Retrieved from http://www2.psy.unsw.edu.au/groups/dass//
   Google Scholar
• Ross HE. 1993. Benzodiazepine use and anxiolytic abuse and dependence in treated alcoholics. Addiction. 88(2):209–218.
   PubMed Web of Science ®Google Scholar
• Schippers GM, Broekman, TG, Buchholz A. 2011. MATE 2.1. manual and protocol. English Ed. W.M. Cox. Nijmegen (Netherlands): Beta Boeken.
   Google Scholar
• Schippers GM, Broekman TG, Buchholz A, Koeter MW, Van Den Brink W. 2010. Measurements in the Addictions for Triage and Evaluation (MATE): an instrument based on the World Health Organization family of international classifications. Addiction. 105:862–871.
   PubMed Web of Science ®Google Scholar
• Schmitz, A. 2016. Benzodiazepine use, misuse, and abuse: a review. Ment Health Clin. 6(3):120–126.
   PubMedGoogle Scholar
• Stichting Farmaceutische Kengetallen (SFK) 2016. The use of benzodiazepines decreases steadily but slowly [article in Dutch: gebruik benzodiazepines daalt gestaag, maar traag]. Pharmaceutisch Weekblad. 151(46).
   Google Scholar
• Stichting Informatie Voorziening Zorg (SIVZ) 2016. Key figures addiction care 2015. www.ladis.eu/File/Key_Figures_Addiction_Care_2015.pdf
   Google Scholar
• Tamburin S, Federico A, Faccini M, Casari R, Morbioli L, Sartore V, Mirijello A, Addolorato G, Lugoboni F. 2017. Determinants of quality of life in high-dose benzodiazepine misusers. IJERPH. 14(1):38.
   Google Scholar
• Tan K, Rudolph U, Lüscher C. 2011. Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci. 34(4):188–197.
   PubMed Web of Science ®Google Scholar
• Treatment Episode Data Set 2011. Substance abuse treatment admissions for abuse of benzodiazepines[Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration. Available from: http://atforum.com/documents/TEDS028BenzoAdmissions.pdf [Google Scholar]
   Google Scholar
• Van Hulten R, Heerdink ER, Bakker A, Leufkens HG. 1999. Benzodiazepine pathways in the chronically ill. Pharmacoepidemiol Drug Saf. 8(5):325–330.
   PubMed Web of Science ®Google Scholar
• World Health Organization 1997. Composite International Diagnostic Interview (CIDI) Version 2.1. Amsterdam (Netherlands): WHO-CIDI Training en Referentie Centrum. Psychiatrisch Centrum AMC, Amsterdam.
   Google Scholar